| Author (Corporate) | European Commission: Press and Communication Service |
|---|---|
| Series Title | Press Release |
| Series Details | IP/04/531 (23.4.04) |
| Publication Date | 23/04/2004 |
| Content Type | News |
|
The European Commission presented a report on 23 April 2004 on the implementation of the 'Life Sciences & Biotechnology Strategy' adopted in 2002. The report highlights that progress has been made, with regard to biotechnology sector players as well as the public and business stakeholders, on the EU action plan's recommendations. Highlights over the last 12 months include the launch of a high level advisory group on 'Competitiveness in Biotechnology', the completion of an EU regulatory framework for Genetically Modified Organisms (GMOs) and initiatives to boost research and increase the number of scientists in the biotech sector. The progress report identifies upcoming issues, including genetic testing and animal biotechnology. Biotechnology covers a wide range of powerful, but also sometimes controversial, technologies. It can make a vital contribution towards the long-term future of industries such as pharmaceuticals, food, agriculture, energy, textiles and chemicals. But success in developing biotechnology also depends on finding solutions to the significant ethical, societal, economic and environmental issues it throws up. The EU strategy provides a consistent approach to these challenges. |
|
| Source Link | Link to Main Source http://europa.eu/rapid/pressReleasesAction.do?reference=IP/04/531&format=HTML&rapid=0&language=EN&guiLanguage=en&display= |
| Related Links |
|
| Subject Categories | Business and Industry |
| Countries / Regions | Europe |
